DAS UNTERNEHMEN | KONZERNLAGEBERICHT | KONZERNABSCHLUSS | LOREM IPSUM 1 MAGAZIN: THEMA LOREM IPSUM SHariNG e xPerTiSe. Cre aTiNG vaLue. Annual Report 2010 Five-year Overview 2006 2007 2008 2009 2010 € million € million € million € million € million Sales 3,321.4 3,572.9 3,786.4 4,028.2 4,422.8 Cost of Goods Sold 1,781.2 1,898.3 2,029.6 2,151.4 2,341.7 Functional expenses 1,205.0 1,297.1 1,366.2 1,432.3 1,595.9 Selling expenses 904.4 972.9 1,031.2 1,091.1 1,218.9 General and administrative expenses 194.8 207.9 204.7 202.1 221.6 research & Development expenses 105.8 116.2 130.3 139.1 155.4 Interim profit 335.2 377.6 390.6 444.5 485.2 operating profit 305.5 348.7 345.7 410.6 456.2 profit before taxes 243.4 283.0 268.8 336.1 389.6 Consolidated Annual Net profit 181.8 217.7 185.1 239.6 277.4 eBItDA 490.7 535.9 545.8 620.5 700.5 Assets 3,025.3 3,332.1 3,708.0 3,975.1 4,686.1 intangible assets (incl. Goodwill) 113.4 124.3 157.1 167.9 218.6 Property, Plant and equipment 1,312.1 1,435.8 1,698.7 1,926.8 2,305.0 inventories 645.9 709.7 726.7 708.5 780.0 Trade accounts receivable 672.7 738.0 767.6 790.1 933.5 equity 1,088.0 1,255.3 1,389.7 1,620.0 1,984.0 liabilities 1,937.3 2,076.8 2,318.3 2,355.1 2,702.0 Pension Obligations 440.9 456.9 470.4 491.8 513.3 Financial Liabilities 798.7 895.7 1,094.5 1,006.4 1,233.4 Trade accounts Payable 159.7 177.4 179.2 210.3 216.8 Investments in property, plant and equipment and Intangible Assets 293.8 349.4 471.0 454.8 575.4 Depreciation and Amortization of property, plant and equipment and Intangible Assets 181.4 182.9 197.8 208.6 238.2 personnel expenditure 1,210.1 1,271.4 1,339.8 1,424.9 1,581.7 employees (annual average) 33,127 35,810 37,601 38,512 40,316 2 0 10 t R R e p o COMPa N y P rOF iL e l B. Braun is one of the world’s leading providers of healthcare solutions. NNUA Through its Hospital Care, aesculap, Out Patient Market, and B. Braun A avitum Divisions, the company supplies medical products and services | to hospitals, physicians in private practice, and the homecare market. B. Braun project manager Cristina Molina (pictured), at the Pharmaceu- ticals Center of excellence, is overseeing the development of the new 3 0 0 2 010 3 B . B R A U N LiFe Nutrition production facility in Melsungen, Germany. 2 SHariNG e xPerTiSe. Cre aTiNG vaLue. Annual Report 2010 Five-year Overview B. BrauN aT a GLaNCe HiGHLiGHTS 2010 2006 2007 2008 2009 2010 Key figures Sales JANUARy The number of B. Braun employees reaches JUNe Medical training on the island of the Gods: million million million million million € € € € € an unprecedented 40,000. B. Braun Medical indonesia begins operations at the asia Sales 3,321.4 3,572.9 3,786.4 4,028.2 4,422.8 Sales by region | IN € mIllIoN Pacific Surgical Training Center in Bali. Cost of Goods Sold 1,781.2 1,898.3 2,029.6 2,151.4 2,341.7 2010 2009 Change in % Manufacturing begins in Switzerland: The new facility Functional expenses 1,205.0 1,297.1 1,366.2 1,432.3 1,595.9 Germany 878 in Crissier will manufacture approximately 12 million Gross Margin (in %) 47.1 46.6 Selling expenses 904.4 972.9 1,031.2 1,091.1 1,218.9 europe & africa 1,692 empty bags for clinical nutrition annually. Net Margin after Taxes (in %) 6.3 5.9 General and administrative expenses 194.8 207.9 204.7 202.1 221.6 asia & australia 616 (without Germany) eBiTDa (in € million) 700.5 620.5 12.9 research & Development expenses 105.8 116.2 130.3 139.1 155.4 eBiTDa Margin (in %) 15.8 15.4 Interim profit 335.2 377.6 390.6 444.5 485.2 Latin america 296 equity ratio (in %) 42.3 40.8 operating profit 305.5 348.7 345.7 410.6 456.2 North america 940 equity ratio including Loans from Shareholders (in %) 43.3 41.8 profit before taxes 243.4 283.0 268.8 336.1 389.6 Net Financial Debt (in € million) 1,183.5 945.7 25.1 Consolidated Annual Net profit 181.8 217.7 185.1 239.6 277.4 totAl € 4.423 mIllIoN Net Financial Debt/eBiTDa 1.7 1.5 10.8 ApRIl B. Braun is named Germany’s “Top engineering oC toBeR B. Braun’s Czech subsidiary creates a new eBItDA 490.7 535.9 545.8 620.5 700.5 e employer 2010.” meeting place: a café in the “House of Medicine” in investments in Property, Plant and equipment Sales by division | IN € mIllIoN ANC Prague. The café was designed by renowned Czech and intangible assets (in € million) 575.4 454.8 26.5 l The new B. Braun office in Havana opens for business. Assets 3,025.3 3,332.1 3,708.0 3,975.1 4,686.1 2 0 1 0 architect eva Jiřičná. S B. Braun Medical international S.L., Havana, Cuba was Depreciation and amortization of Property, Plant and equipment t A G intangible assets (incl. Goodwill) 113.4 124.3 157.1 167.9 218.6 OPM 555 t established by the Spanish holding company B. Braun and intangible assets (in € million) 238.2 208.6 14.2 IGH Property, Plant and equipment 1,312.1 1,435.8 1,698.7 1,926.8 2,305.0 l Medical international SL , rubí, Spain. Personnel expenditure (in € million) 1,581.7 1,424.9 11.0 inventories 645.9 709.7 726.7 708.5 780.0 IGH B. Braun avitum 475 Hospital Care 2,087 R A U N A employees (annual average) 41,666 39,504 5.5 H 672.7 738.0 767.6 790.1 933.5 Trade accounts receivable Other 26 B . B equity 1,088.0 1,255.3 1,389.7 1,620.0 1,984.0 liabilities 1,937.3 2,076.8 2,318.3 2,355.1 2,702.0 aesculap 1,281 Pension Obligations 440.9 456.9 470.4 491.8 513.3 Financial Liabilities 798.7 895.7 1,094.5 1,006.4 1,233.4 income structure mAy The B. Braun Group and its employees around DeCemBeR The Supervisory Board elects Dr. Heinz- Trade accounts Payable 159.7 177.4 179.2 210.3 216.8 totAl € 4.423 mIllIoN the world donate € 230,000 to help build a hospital in walter Große to succeed Prof. Dr. h.c. Ludwig Georg earthquake-ravaged Haiti. Braun, who will retire on March 31, 2011. Otto-Philipp 2010 2009 Change Investments in property, plant and Braun and Dr. annette Beller are appointed to the in % employees a new factory for surgical instruments is opened in € million % € million % equipment and Intangible Assets 293.8 349.4 471.0 454.8 575.4 radzyń Podlaski, Poland. Management Board. Depreciation and Amortization of property, Sales 4,422.8 100.0 4,028.2 100.0 9.8 plant and equipment and Intangible Assets 181.4 182.9 197.8 208.6 238.2 Cost of Goods Sold 2,341.7 52.9 2,151.4 53.4 8.8 employees by region Gross profit 2,081.1 47.1 1,876.8 46.6 10.9 personnel expenditure 1,210.1 1,271.4 1,339.8 1,424.9 1,581.7 Selling expenses 1,218.9 27.6 1,091.1 27.1 11.7 12,663 12,157 employees (annual average) 33,127 35,810 37,601 38,512 40,316 General and 12,000 11,251 10,672 administrative expenses 221.6 5.0 202.1 5.0 9.7 9,243 research and 9,000 8,265 2 0 10 t Development expenses 155.4 3.5 139.1 3.5 11.7 R Interim profit 485.2 11.0 444.5 11.0 9.1 6,000 5,486 5,486 R e p o Other Operating income COMPa N y P rOF iL e l and expenses – 29.0 – 0.7 – 34.0 – 0.8 14.5 2,924 3,023 3,000 B. Braun is one of the world’s leading providers of healthcare solutions. NNUA operating profit 456.2 10.3 410.6 10.2 11.1 Through its Hospital Care, aesculap, Out Patient Market, and B. Braun A Net Financial income (Loss) – 66.6 – 1.5 – 74.5 – 1.8 10.6 avitum Divisions, the company supplies medical products and services | to hospitals, physicians in private practice, and the homecare market. profit before taxes 389.6 8.8 336.1 8.3 15.9 Germany europe & africa North america Latin america asia & australia income Taxes 112.3 2.5 96.5 2.4 16.3 ( without Germany) B. Braun project manager Cristina Molina (pictured), at the Pharmaceu- ticals Center of excellence, is overseeing the development of the new Consolidated Annual Net profit 277.4 6.3 239.6 5.9 15.8 DeC 31, 2009 totAl: 39.504 DeC 31, 2010 totAl: 41.666 3 0 0 2 010 3 B .